{"id":17767,"date":"2023-04-04T15:38:18","date_gmt":"2023-04-04T13:38:18","guid":{"rendered":"https:\/\/www.curus.se\/nyheter\/curus-acquires-swedens-largest-prescribing-app\/"},"modified":"2023-04-04T15:38:18","modified_gmt":"2023-04-04T13:38:18","slug":"curus-acquires-swedens-largest-prescribing-app","status":"publish","type":"post","link":"https:\/\/www.curus.se\/en\/nyheter\/curus-acquires-swedens-largest-prescribing-app\/","title":{"rendered":"Curus acquires Sweden’s largest prescribing app"},"content":{"rendered":"

More than 25,000 doctors use the e-Prescription app to prescribe medicines.
\nNow Health Amplify AB, the company behind the app, is acquired by the investment company Curus.
\nThe acquisition is made through their subsidiary Add Health Media. <\/strong><\/p>\n

– “e-Prescribing is an excellent complement to our digital health portfolio,” says Erik Olsson Nyr\u00e9n, Investment Manager at Curus. <\/strong> With over 60 percent of the medical profession connected, e-Prescribing<\/a> is Sweden’s largest prescription platform.
\nThe service is an application that makes it possible to write electronic prescriptions for medicines and assistive devices directly in the mobile phone.
\nThe app is aimed at doctors, dentists, midwives and nurses with prescribing rights. Curus<\/a> subsidiary Add Health Media<\/a>, the acquiring party, sees synergies with its other digital platforms.
\n– “Through our website PraktiskMedicin.se<\/a> we reach most of the medical profession and now we can offer e-prescribing to them.
\nAt the same time, we want to use our solid knowledge in digital development, training and data management to develop e-Prescribing further,” says Rikard Ekberg, CEO of Add Health Media.
\ne-Prescribing was developed by physician and entrepreneur Daniel W\u00e4nn, CEO and founder of Health Amplify.
\nHe saw the need for an easy-to-use mobile app to be able to quickly prescribe medicines while maintaining safety even when you are not at your regular workplace – Simplicity and mobility have been the key success factors.
\nThanks to doctors recommending the app to each other, e-Prescribing has gained market share organically without significant marketing.
\nCurus and Add Health Media are the right fit to develop the service further,” says Daniel W\u00e4nn.
\nCurus is an investment company focused on developing the future of healthcare.
\nThe company has invested in over 25 growth companies in e-health since 2016 and acquires profitable companies in the health sector that can be developed further.
\n– “e-Prescribing fits well into our strategy of building the healthcare of the future, where it should be easy and convenient for healthcare professionals to carry out their work regardless of where they are,” says Erik Olsson Nyr\u00e9n, who is also Chairman of the Board of Add Health Media.
\n“More and more care will be provided in the home, which requires digital services that are mobile, simple and secure.  For more information <\/strong>Erik Olsson Nyr\u00e9n, Investment Manager Curus, Chairman of the Board Add Health Media, erik.olsson.nyren@curus.se,<\/a>+46 70 837 73 54 Rikard Ekberg, CEO, Add Health Media rikard.ekberg@addhealthmedia.com,<\/a>+46 70 921 61 23 <\/p>\n","protected":false},"excerpt":{"rendered":"

More than 25,000 doctors use the e-Prescription app to prescribe medicines. Now Health Amplify AB, the company behind the app, is acquired by the investment company Curus. The acquisition is made through their subsidiary Add Health Media. – “e-Prescribing is an excellent complement to our digital health portfolio,” says Erik Olsson Nyr\u00e9n, Investment Manager at […]<\/p>\n","protected":false},"author":24,"featured_media":17704,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[315,301,303,317,304],"tags":[],"class_list":["post-17767","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-add-health-media-en-2","category-e-halsa-en","category-nyheter-en","category-practicalmedicine","category-pressmeddelande-en"],"_links":{"self":[{"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/posts\/17767","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/users\/24"}],"replies":[{"embeddable":true,"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/comments?post=17767"}],"version-history":[{"count":0,"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/posts\/17767\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/media\/17704"}],"wp:attachment":[{"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/media?parent=17767"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/categories?post=17767"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.curus.se\/en\/wp-json\/wp\/v2\/tags?post=17767"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}